1G表型检测在美国-墨西哥边境痰标本中检测结核分枝杆菌及耐药性的准确性
该横断面研究纳入墨西哥两个小城426例疑似肺结核患者的痰标本,评估第一代低复杂度表型1G检测对比涂片镜检和MGIT培养及药敏的准确性。1G检测对Mtb灵敏度≥98%,对利福平、异烟肼和莫西沙星药敏灵敏度100%、特异度分别为91%、94%和97%,污染率低于MGIT,检测时间17天。结论认为1G检测是资源有限地区替代培养法的实用表型诊断方法。
要点
- 1G检测对Mtb灵敏度≥98%,药敏灵敏度100%,特异度91%-97%。
- 1G检测污染率3.5%低于MGIT的8.1%(P<.05)。
- 1G检测17天完成检测和药敏,MGIT需21天(7+14天)。
核心结论
- 1G检测是一种低复杂度表型结核诊断方法,可实际替代当前基于培养的检测。
研究设计与样本
- 横断面研究,纳入墨西哥两个小城426例疑似肺结核患者的痰标本。
- 1G检测与地区表型检测(抗酸杆菌涂片镜检和MGIT培养)及MGIT药敏(异烟肼、利福平、莫西沙星)进行比较。
主要发现
- 1G检测对Mtb检测灵敏度≥98%。
- 1G检测对药敏的灵敏度为100%,特异度利福平91%、异烟肼94%、莫西沙星97%。
- 1G检测污染率3.5%,低于MGIT的8.1%(P<.05)。
- 1G检测Mtb和同步药敏的检出时间为17天,MGIT药敏需两步:Mtb检测7天加药敏14天,共21天。
- 研究现场连续入组受试者中耐药结核患病率为14%,被动报告为6%。
临床怎么用
- 在缺乏分子工具、资源和专业知识的分散诊所中,1G检测可作为替代培养的实用表型诊断方法。
- 未来需开展研究评估1G检测在分散诊所的实施。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: With >10 million new tuberculosis (TB) cases per year, a limitation to TB control is the lack of simple and accurate tests for diagnosis and drug susceptibility testing (DST) in endemic regions. We evaluated the accuracy of the first-generation, low-complexity phenotypic TB test (1G test), designed for simultaneous Mycobacterium tuberculosis (Mtb) detection and resistance to isoniazid, rifampicin, and moxifloxacin, suitable for resource-limited settings. METHODS: A cross-sectional study was conducted with sputa from 426 possible pulmonary TB cases from 2 small Mexican cities bordering Texas. The 1G test was compared against phenotypic TB detection tests in the region, specifically acid-fast bacilli smear microscopy and Mycobacteria Growth Indicator Tube (MGIT) culture, as well as MGIT-DST for resistance to isoniazid, rifampicin, and moxifloxacin. RESULTS: The 1G test demonstrated ≥98% sensitivity for Mtb detection; 100% sensitivity and 91% (rifampicin), 94% (isoniazid), and 97% (moxifloxacin) specificity for DST; and less contamination than the MGIT (3.5% vs 8.1%, P < .05). The 1G test time to detection of Mtb and simultaneous DST was 17 days, while the MGIT-DST required 2 steps: 7 days for Mtb detection plus 14 more days for DST (21 days total). Our study site drug-resistant TB prevalence was 14% when testing all consecutively enrolled participants vs 6% by passive reporting. CONCLUSIONS: The 1G test is a low-complexity phenotypic TB diagnostic method that is a practical replacement to current culture-based tests. Future studies are warranted to evaluate implementation of the 1G test in decentralized clinics that lack molecular tools, resources, and expertise.
引用
- Aguirre M, Ayala D, Garcia JI, et al. Accuracy of the Phenotypic 1G Test to Detect Mycobacterium tuberculosis and Drug Resistance From Sputa in the US-Mexico Border. J Infect Dis. 2026. PMID: 41432525. doi:10.1093/infdis/jiaf638
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。